Published in Hepatology on February 01, 1992
Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. J Clin Invest (1998) 1.68
Mechanisms of disease: Inborn errors of bile acid synthesis. Nat Clin Pract Gastroenterol Hepatol (2008) 1.13
Bile acids: the role of peroxisomes. J Lipid Res (2009) 0.93
Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines. Mol Genet Metab (2015) 0.90
A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts. J Inherit Metab Dis (2008) 0.90
Zellweger spectrum disorders: clinical overview and management approach. Orphanet J Rare Dis (2015) 0.87
ACOX2 deficiency: A disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment. Proc Natl Acad Sci U S A (2016) 0.78
Identification of a novel PEX14 mutation in Zellweger syndrome. BMJ Case Rep (2009) 0.75
Cholic acid therapy in Zellweger spectrum disorders. J Inherit Metab Dis (2016) 0.75
Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev (1994) 3.97
Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood (2001) 3.84
Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet (2001) 3.28
Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr (2001) 2.97
Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet (1997) 2.95
Twenty four hour manometric recording of colonic motor activity in healthy man. Gut (1987) 2.75
Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci U S A (2001) 1.84
Prevention of cardiac surgery-associated acute kidney injury. Int J Artif Organs (2008) 1.69
Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study. Br J Anaesth (2006) 1.64
Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis. J Clin Invest (1988) 1.62
Gastric acidity and gastroesophageal reflux patterns in patients with esophagitis. Gastroenterology (1992) 1.58
Autoantibodies in Down's syndrome. Lancet (1966) 1.58
Incidence and determinants of hepatitis C virus infection among individuals at risk of sexually transmitted diseases attending a human immunodeficiency virus type 1 testing program. Sex Transm Dis (1997) 1.57
Lymphocytes bearing the gamma delta T cell receptor in acute Brucella melitensis infection. Eur J Immunol (1993) 1.53
Giardia lamblia infestation reveals underlying Whipple's disease in a patient with longstanding constipation. Am J Gastroenterol (1991) 1.48
Quality control study of H2 breath testing for the diagnosis of carbohydrate malabsorption in Italy. The "Tenue Club" Group. Ital J Gastroenterol Hepatol (1997) 1.48
Hepatitis B virus antigens in peripheral blood mononuclear cells during the course of viral infection. Clin Immunol Immunopathol (1994) 1.46
Selective endoscopic retrograde cholangiography and preoperative bile duct stone removal in patients scheduled for laparoscopic cholecystectomy: a prospective study. Am J Gastroenterol (1996) 1.45
Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol (2007) 1.45
Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr (1998) 1.45
Physician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trials. J Natl Cancer Inst (1994) 1.44
Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl (2009) 1.43
Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis. Am J Gastroenterol (1990) 1.41
Hepatitis G virus in intramuscular and intravenous immunoglobulin products manufactured in Europe. Transfusion (1999) 1.40
Esophageal motor disorders in patients evaluated for dysphagia and/or noncardiac chest pain. Dysphagia (1992) 1.39
Intragastric pH monitoring during antisecretory therapy in patient with gastrointestinal bleeding. Am J Gastroenterol (1989) 1.38
Nucleic acid amplification technology screening for HBV DNA in Italy: routine application. Report on the first HBV DNA-positive HBsAG-negative donor. Transfus Med (2005) 1.38
Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide. Dig Dis Sci (1986) 1.37
Colonic mass movements in idiopathic chronic constipation. Gut (1988) 1.36
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Natl Acad Sci U S A (2001) 1.31
The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation. Gut (2005) 1.29
Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J Cell Sci (1999) 1.29
Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha. Gut (1994) 1.27
HIV seroprevalence among 304 female prostitutes from four Italian towns. AIDS (1989) 1.27
Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology (1999) 1.24
Extremely thermostable glutamate dehydrogenase from the hyperthermophilic archaebacterium Pyrococcus furiosus. Eur J Biochem (1991) 1.24
Counter-regulatory role of bile acid activated receptors in immunity and inflammation. Curr Mol Med (2010) 1.24
Lymphocytes bearing the gamma delta T-cell receptor in acute toxoplasmosis. Immunology (1992) 1.24
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. Gastroenterology (1999) 1.22
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol (2005) 1.22
Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. Gastroenterology (1997) 1.22
Human breast milk T lymphocytes display the phenotype and functional characteristics of memory T cells. Eur J Immunol (1990) 1.20
Modulation of erythrocyte Ca2+-ATPase by selective calpain cleavage of the calmodulin-binding domain. J Biol Chem (1989) 1.18
Twenty-four hour recordings of colonic motility in patients with diverticular disease: evidence for abnormal motility and propulsive activity. Dis Colon Rectum (2001) 1.17
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet (2000) 1.16
Mongolism and thyroid autoimmunity. Lancet (1965) 1.15
World Health Organization collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology assays. Vox Sang (2005) 1.15
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. Proc Natl Acad Sci U S A (2001) 1.14
IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs. J Immunol (2000) 1.14
Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. J Immunol (1999) 1.13
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology (2000) 1.13
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2007) 1.13
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis (2005) 1.13
Role of tumor necrosis factor alpha release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology (1995) 1.10
Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum (1997) 1.09
Biofeedback for pelvic floor dysfunction in constipation. BMJ (2004) 1.09
Differential effects of epidermal growth factor and transforming growth factor-beta on synthesis of Mr = 35,000 surfactant-associated protein in fetal lung. J Biol Chem (1987) 1.08
Hypogonadism and metabolic syndrome. J Endocrinol Invest (2011) 1.07
Gynecomastia during omeprazole therapy. N Engl J Med (1991) 1.07
The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J (2000) 1.06
Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity. Cancer Res (1985) 1.05
Lymphocytes bearing the T cell receptor gamma delta in human breast milk. Arch Dis Child (1990) 1.05
Hepatitis B and Delta virus infection among heterosexuals, homosexuals and bisexual men. Eur J Epidemiol (1988) 1.04
Cardiac protection by volatile anesthetics in non-cardiac surgery? A meta-analysis of randomized controlled studies on clinically relevant endpoints. HSR Proc Intensive Care Cardiovasc Anesth (2009) 1.03
Further delineation of the molecular pathology of Wilson disease in the Mediterranean population. Hum Mutat (1998) 1.03
Identification of muscarinic receptor subtype mediating colonic response to eating. Dig Dis Sci (1985) 1.03
Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology (1996) 1.03
Airway management in an infant with congenital centrofacial dysgenesia. Br J Anaesth (2002) 1.02
Behavioral and psychotic symptoms of dementia (BPSD) improvements in a special care unit: a factor analysis. Arch Gerontol Geriatr (2007) 1.02
Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology (2000) 1.00
Gaucher disease: enzyme therapy in the acute neuronopathic variant. Am J Med Genet (1997) 1.00
Autonomic dysfunction and upper digestive functional disorders in untreated adult coeliac disease. Eur J Clin Invest (1997) 1.00
False positive EBNA IgM and IgG antibody tests for infectious mononucleosis in children. Pediatrics (1994) 1.00
Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis. J Clin Pathol (1981) 1.00
Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy. Dig Dis Sci (1996) 0.99
GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut (2006) 0.99
T lymphocytes bearing the gamma delta T cell receptor are susceptible to steroid-induced programmed cell death. Scand J Immunol (1995) 0.99
Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells. Carcinogenesis (2001) 0.98
Mechanism of non-steroidal anti-inflammatory drug-gastropathy. Dig Liver Dis (2001) 0.98
Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus. Am J Gastroenterol (1989) 0.98
Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study. Hepatology (1992) 0.98
Upper gastrointestinal motor abnormalities in children with active celiac disease. J Pediatr Gastroenterol Nutr (1995) 0.97
Serum IL-10 levels in HIV-positive subjects: correlation with CDC stages. J Biol Regul Homeost Agents (1995) 0.97
Impaired colonic motor response to cholinergic stimulation in patients with severe chronic idiopathic (slow transit type) constipation. Dig Dis Sci (1993) 0.97
Biochemical mechanisms of glucose-6-phosphate dehydrogenase deficiency. Proc Natl Acad Sci U S A (1978) 0.96
Cromolyn versus nedocromil: duration of action in exercise-induced asthma in children. J Allergy Clin Immunol (1995) 0.95
Human colonic motility: physiological aspects. Int J Colorectal Dis (1995) 0.95
Edrophonium chloride for testing colonic contractile activity in man. Acta Physiol Scand (1991) 0.95
Interstitial cells of Cajal, enteric nerves, and glial cells in colonic diverticular disease. J Clin Pathol (2005) 0.94
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. Br J Pharmacol (2001) 0.94